Westhofen Thilo, Magistro Giuseppe, Stief Christian, Gratzke Christian
Ludwig-Maximilians-Universität München, Urologische Klinik und Poliklinik, Klinikum der Universität München, München.
Klinikum Großhadern/Innenstadt, Ludwig-Maximilians-Universität München, Urologische Klinik und Poliklinik, München.
Aktuelle Urol. 2018 Dec;49(6):515-518. doi: 10.1055/a-0759-9185. Epub 2018 Dec 6.
Minimally-invasive treatment options for patients with LUTS due to benign prostatic obstruction (BPO) become more and more important because they provide equal long-term efficacy compared with the reference method TURP, while having a more favourable safety profile. There are promising results for PUL (Prostatic Urethral Lift - UroLift) with low complication rates. UroLift is clearly superior regarding the preservation of sexual functions without impairment of ejaculatory function.
对于因良性前列腺梗阻（BPO）导致下尿路症状（LUTS）的患者，微创治疗方案变得越来越重要，因为与参考方法经尿道前列腺切除术（TURP）相比，它们具有相同的长期疗效，同时安全性更高。前列腺尿道悬吊术（PUL，即UroLift）取得了令人鼓舞的成果，并发症发生率较低。在保留性功能且不损害射精功能方面，UroLift明显更具优势。
